These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19469252)

  • 1. [Erythropoietin in patients with chronic heart failure].
    Makarova NA; Shaposhnik II; Zakharov IuM
    Klin Med (Mosk); 2009; 87(3):31-4. PubMed ID: 19469252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
    Wang W; Zhang MH; Yu Y; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experience in the treatment of iron deficiency anemia with ferro-folgamma].
    Nikitin EN; Krasnoperova OV; Nikitin IuE
    Klin Med (Mosk); 2009; 87(3):64-7. PubMed ID: 19469261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anemia and chronic heart failure implications and treatment options.
    Anand IS
    J Am Coll Cardiol; 2008 Aug; 52(7):501-11. PubMed ID: 18687241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anemia in patients with chronic cardiac failure].
    Provotorov VM; Avdeeva SA
    Klin Med (Mosk); 2012; 90(3):55-9. PubMed ID: 22690568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure.
    van der Putten K; Braam B; Jie KE; Gaillard CA
    Nat Clin Pract Nephrol; 2008 Jan; 4(1):47-57. PubMed ID: 18094727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor necrosis factor in blood plasma and morphofunctional parameters of the hart in patients with chronic heart failure complicated by a course of ischemic heart disease. Dynamics under effect of treatment].
    Ol'binskaia LI; Ignatenko SB; Markin SS
    Ter Arkh; 2003; 75(2):54-8. PubMed ID: 12685394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic heart failure in patients with cardiac amyloidosis].
    Solomakhina NI; Varshavskiĭ VA; Gundarova LV; Golitsina EP; Shchekochikhin DIu
    Klin Med (Mosk); 2009; 87(3):26-30. PubMed ID: 19469251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [N-terminal fragment of the brain natriuretic peptide and proinflammatory cytokines in patients with ischemic heart disease].
    Shalaev SV; Volkova SIu
    Ter Arkh; 2009; 81(5):30-6. PubMed ID: 19537583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia of chronic disease and defective erythropoietin production in patients with celiac disease.
    Bergamaschi G; Markopoulos K; Albertini R; Di Sabatino A; Biagi F; Ciccocioppo R; Arbustini E; Corazza GR
    Haematologica; 2008 Dec; 93(12):1785-91. PubMed ID: 18815191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New applications of erythropoietin in cardiovascular disease: from haematopoiesis to cardiac protection].
    van der Meer P; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(16):923-7. PubMed ID: 18561787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congestive heart failure-related anemia and a role for erythropoietin.
    Akram K; Pearlman BL
    Int J Cardiol; 2007 May; 117(3):296-305. PubMed ID: 16901559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The cardio-renal anemia syndrome: what is it? With a focus on congestive heart failure].
    Petersen H; Jensen KE; Haghfelt TH
    Ugeskr Laeger; 2006 May; 168(19):1864-7. PubMed ID: 16756804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha.
    Tsopra OA; Ziros PG; Lagadinou ED; Symeonidis A; Kouraklis-Symeonidis A; Thanopoulou E; Angelopoulou MK; Vassilakopoulos TP; Pangalis GA; Zoumbos NC
    Acta Haematol; 2009; 121(4):187-95. PubMed ID: 19468203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anemia management in heart failure: a thick review of thin data.
    McBride BF; White CM
    Pharmacotherapy; 2004 Jun; 24(6):757-67. PubMed ID: 15222666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia in chronic heart failure: etiology and treatment options.
    Westenbrink BD; de Boer RA; Voors AA; van Gilst WH; van Veldhuisen DJ
    Curr Opin Cardiol; 2008 Mar; 23(2):141-7. PubMed ID: 18303527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anemia of heart failure.
    Silverberg DS; Wexler D; Palazzuoli A; Iaina A; Schwartz D
    Acta Haematol; 2009; 122(2-3):109-19. PubMed ID: 19907148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heart failure: erythropoietin in treatment of anemia].
    Büyüklü M
    Anadolu Kardiyol Derg; 2007 Sep; 7(3):342-3. PubMed ID: 17785241
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?
    Pagourelias ED; Koumaras C; Kakafika AI; Tziomalos K; Zorou PG; Athyros VG; Karagiannis A
    Angiology; 2009; 60(1):74-81. PubMed ID: 18413330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.